Jeffrey T. L. Smith, Senior VP Translational Medicine at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 2,500 shares at $22.61 ($57K) on 2016-12-01, disclosed to the SEC on 2016-12-05.
Open-market sale of $57k ALDR by Senior VP Translational Medicine. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ZYME | SELL | 2025-01-06 | $332K | — | Filing → |
| ALDR | SELL | 2019-09-18 | $1.2M | — | Filing → |
| ALDR | SELL | 2018-12-04 | $140K | — | Filing → |